IP Library Granted Patent US 9,057,079
Granted Patent B2
US 9,057,079 · App. 10/543,792 · Granted Jun 16, 2015

Expression elements

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,057,079
App. No.
10/543,792
Granted
Jun 16, 2015
Kind
B2
Abstract

The invention relates to improved genetic elements providing high levels of expression of operably-linked genes in a variety of tissues. In particular, fragments of unmethylated, CpG islands of less than 2 kb are shown to provide enhanced transgene expression and have advantages in terms of vector construction and cloning capacity.

Claims (26)

1. An isolated polynucleotide comprising:

a) an extended methylation-free CpG island;

b) an expressible open reading frame, operably linked to said extended methylation-free CpG island;

c) a promoter, operably-linked to said open reading frame, wherein said promoter is not naturally linked to said CpG island;

wherein said CpG island is not more than 2 kb in size and comprises the sequence set forth in SEQ ID NO:1 or SEQ ID NO:2, and wherein reproducible expression of said open reading frame is obtained in the presence of the CpG island.

2. A polynucleotide according to claim 1 , wherein SEQ ID NO:2 comprises a 987 bp BspE1-Esp3I restriction fragment.

3. A vector comprising the polynucleotide of any of claim 1 or 2 .

4. A vector according to claim 3 wherein the vector is an integrating vector.

5. A vector according to claim 3 wherein the vector is a plasmid.

6. A vector according to claim 3 wherein the operably linked open reading frame is a therapeutic nucleic acid.

7. A vector according to claim 3 , comprising any of SEQ ID NOs 1 or 2, a CMV promoter, a multiple cloning site, a polyadenylation sequence and genes encoding selectable markers under suitable control elements.

8. A host cell comprising the polynucleotide of any of claim 1 or 2 .

9. A pharmaceutical composition comprising the polynucleotide according to any of claim 1 or 2 in combination with a pharmaceutically acceptable excipient.

10. A method for obtaining a desired gene product comprising expressing the polynucleotide according to any of claim 1 or 2 in a cell culture system in order to obtain a desired gene product, wherein the open reading frame encodes the desired gene product.

11. A method for increasing the expression of an endogenous gene comprising inserting the polynucleotide comprising SEQ ID NO 1 or 2 into the genome of a cell in a position operably associated with the endogenous gene thereby increasing the level of expression of the gene.

12. An isolated polynucleotide comprising:

a) an extended methylation-free CpG island;

b) an expressible open reading frame, operably linked to said extended methylation-free CpG island;

c) a promoter, operably-linked to said open reading frame, wherein said promoter

is not naturally linked to said CpG island;

wherein said CpG island is not more than 2 kb in size and comprises the sequence set forth in SEQ ID NO:2, and wherein reproducible expression of said open reading frame is obtained in the presence of the CpG island.

13. An isolated polynucleotide comprising:

a) an extended methylation-free CpG island;

b) an expressible open reading frame, operably linked to said extended methylation-free CpG island;

c) a promoter, operably-linked to said open reading frame, wherein said promoter is not naturally linked to said CpG island;

wherein said CpG island is not more than 2 kb in size and comprises the sequence set forth in SEQ ID NO:1, and wherein reproducible expression of said open reading frame is obtained in the presence of the CpG island.

Assignments (2)
CHANGE OF ADDRESS Recorded Feb 15, 2018
From: EMD MILLIPORE CORPORATION
To: EMD MILLIPORE CORPORATION
Reel/Frame 045341/0166 →
CHANGE OF NAME Recorded Jan 31, 2012
From: MILLIPORE CORPORATION
To: EMD MILLIPORE CORPORATION
Reel/Frame 027620/0891 →